179 related articles for article (PubMed ID: 24556800)
21. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
[TBL] [Abstract][Full Text] [Related]
22. Over-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-catenin.
Wu N; Liu C; Bai C; Han YP; Cho WC; Li Q
Int J Mol Sci; 2013 May; 14(6):10749-60. PubMed ID: 23702845
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
[TBL] [Abstract][Full Text] [Related]
24. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
Wang FF; Wang S; Xue WH; Cheng JL
Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372
[TBL] [Abstract][Full Text] [Related]
25. Expression of MicroRNA-325-3p and its potential functions by targeting HMGB1 in non-small cell lung cancer.
Yao S; Zhao T; Jin H
Biomed Pharmacother; 2015 Mar; 70():72-9. PubMed ID: 25776482
[TBL] [Abstract][Full Text] [Related]
26. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival.
Silva J; García V; Zaballos Á; Provencio M; Lombardía L; Almonacid L; García JM; Domínguez G; Peña C; Diaz R; Herrera M; Varela A; Bonilla F
Eur Respir J; 2011 Mar; 37(3):617-23. PubMed ID: 20595154
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
29. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
30. Nicotine upregulates FGFR3 and RB1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of miR-99b and miR-192.
Du X; Qi F; Lu S; Li Y; Han W
Biomed Pharmacother; 2018 May; 101():656-662. PubMed ID: 29518612
[TBL] [Abstract][Full Text] [Related]
31. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
33. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
34. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
Huang J; Sun C; Wang S; He Q; Li D
Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
[TBL] [Abstract][Full Text] [Related]
35. Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN.
Jin YY; Chen QJ; Xu K; Ren HT; Bao X; Ma YN; Wei Y; Ma HB
Mol Cell Biochem; 2016 Nov; 422(1-2):161-170. PubMed ID: 27644195
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1.
Meng F; Zhang L; Shao Y; Ma Q; Lv H
Int J Clin Exp Pathol; 2015; 8(11):13853-63. PubMed ID: 26823698
[TBL] [Abstract][Full Text] [Related]
37. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
[TBL] [Abstract][Full Text] [Related]
38. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
39. MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer.
Dong W; Yao C; Teng X; Chai J; Yang X; Li B
Tumour Biol; 2016 Mar; 37(3):2973-85. PubMed ID: 26415732
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-140-3p inhibits proliferation and promotes apoptosis in non-small cell lung cancer by targeting MDIG.
Yu M; Fan Y; Zhao Y; Tang Y
Environ Toxicol; 2024 Mar; 39(3):1521-1530. PubMed ID: 38009637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
